Niosomal drug delivery systems for ocular disease-recent advances and future prospects
Open accessThe DOI matches its Crossref record; 124 of the 126 references it cites were found in a registry or an index.
Abstract
The eye is a complex organ consisting of several protective barriers and particular defense mechanisms. Since this organ is exposed to various infections, genetic disorders, and visual impairments it is essential to provide necessary drugs through the appropriate delivery routes and vehicles. The topical route of administration, as the most commonly used approach, maybe inefficient due to low drug bioavailability. New generation safe, effective, and targeted drug delivery systems based on nanocarriers have the capability to circumvent limitations associated with the complex anatomy of the eye. Nanotechnology, through various nanoparticles like niosomes, liposomes, micelles, dendrimers, and different polymeric vesicles play an active role in ophthalmology and ocular drug delivery systems. Niosomes, which are nano-vesicles composed of non-ionic surfactants, are emerging nanocarriers in drug delivery applications due to their solution/storage stability and cost-effectiveness. Additionally, they are biocompatible, biodegradable, flexible in structure, and suitable for loading both hydrophobic and hydrophilic drugs. These characteristics make niosomes promising nanocarriers in the treatment of ocular diseases. Hereby, we review niosome based drug delivery approaches in ophthalmology starting with different preparation methods of niosomes, drug loading/release mechanisms, characterization techniques of niosome nanocarriers and eventually successful applications in the treatment of ocular disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Niosomes, which are comprised of uncharged single-chain surfactant and cholesterol94,95 have also shown limited success potential as non-viral gene delivery systems96–101 due to improved transfection efficiency, biocompatibility, and cellular uptake, in addition to effects on intracellular trafficking.102”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [97]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Higuchi, T. (1963) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600521210 · Cited by 4,884
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918 · cited 1×
“For ocular applications, particles should have narrow size distribution and small polydispersity index values as lower PDI values are better for the uptake of nanoparticles and posterior internalization [97].”
BackgroundSzoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Non-ionic surfactant based vesicles (niosomes) in drug delivery
Uchegbu, I. F., & Vyas, S. P. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00169-0 · Cited by 1,020
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Nano-niosomes as nanoscale drug delivery systems: An illustrated review
Moghassemi, S., & Hadjizadeh, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.015 · Cited by 797
Research works printed but not linked: 3
- More, 2019, Niosomal Drug Delivery-A Comprehensive Review, Asian J. Pharm., 12, S1159
- Lakshmi, 2011, Phase II study of topical niosomal urea gel-an adjuvant in the treatment of psoriasis, Int. J. Pharm. Sci. Rev. Res., 7, 1
- Biswas, 2017, Niosomes in ocular drug delivery, Eur. J. Pharm. Med. Res., 4, 813
Cited by
Alkilani, A. Z., Nasereddin, J., Hamed, R., Nimrawi, S., Hussein, G., Abo-Zour, H., & Donnelly, R. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061152 · Cited by 201
Current advances in niosomes applications for drug delivery and cancer treatment
Moammeri, A., Chegeni, M. M., Sahrayi, H., Ghafelehbashi, R., Memarzadeh, F., Mansouri, A., Akbarzadeh, I., Abtahi, M. S., Hejabi, F., & Ren, Q. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100837 · Cited by 195
Hyaluronic acid in ocular drug delivery
Zhang, X., Wei, D., Xu, Y., & Zhu, Q. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118006 · Cited by 196
Synthesis and Potential Applications of Lipid Nanoparticles in Medicine
Musielak, E., Feliczak-Guzik, A., & Nowak, I. (2022) · Materials · doi:10.3390/ma15020682 · Cited by 159
Nanomaterials as Nanofertilizers and Nanopesticides: An Overview
Okey‐Onyesolu, C. F., Hassanisaadi, M., Bilal, M., Barani, M., Rahdar, A., Iqbal, J., & Kyzas, G. Z. (2021) · ChemistrySelect · doi:10.1002/slct.202102379 · Cited by 178
Metadata
- Authors
- Durak, S., Esmaeili Rad, M., Alp Yetisgin, A., Eda Sutova, H., Kutlu, O., Cetinel, S., & Zarrabi, A.
- Affiliations
- Sabancı Üniversitesi (TR)
- Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Turkey
- Corresponding author
- Zarrabi, Ali
- Venue
- Nanomaterials
- Publisher
- MDPI AG
- Published
- 2020-06-18
- Volume
- 10
- Issue
- 6
- Pages
- 1191
- ISSN
- 2079-4991 (ISSN-L)
- PMC
- PMC7353242
- OpenAlex
- W3036547471
- Cited by
- 196
- References
- 126
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 44 · 2023: 40 · 2022: 27 · 2021: 22 · 2020: 2
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nanomaterials (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Sabanci University (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- SUNUM (I.A.SN-19-00005 (S.C.) and I.A.SN-19-00001 (A.Z.))
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- niosomes, ocular drug delivery, nonionic surfactants, nanocarriers, eye diseases, drug loading and release, niosome characterization, topical ocular administration, drug bioavailability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Niosomal drug delivery systems for ocular disease-recent advances and future prospects. https://app.cochat.ai/papers/10.3390/nano10061191
- The paper
- Durak, S., Esmaeili Rad, M., Alp Yetisgin, A., Eda Sutova, H., Kutlu, O., Cetinel, S., & Zarrabi, A. (2020). Niosomal drug delivery systems for ocular disease-recent advances and future prospects. Nanomaterials. https://doi.org/10.3390/nano10061191
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.